Show simple item record

dc.contributor.authorShriver, Zachary H.
dc.contributor.authorCapila, Ishan
dc.contributor.authorVenkataraman, Ganesh
dc.contributor.authorSasisekharan, Ram
dc.date.accessioned2014-08-22T17:02:25Z
dc.date.available2014-08-22T17:02:25Z
dc.date.issued2012
dc.identifier.isbn978-3-642-23055-4
dc.identifier.isbn978-3-642-23056-1
dc.identifier.issn0171-2004
dc.identifier.issn1865-0325
dc.identifier.urihttp://hdl.handle.net/1721.1/88991
dc.descriptionavailable in PMC 2013 August 28en_US
dc.description.abstractThe structural microheterogeneity of heparin and heparan sulfate is one of the major reasons for the multifunctionality exhibited by this class of molecules. In a physiological context, these molecules primarily exert their effects extracellularly by mediating key processes of cellular cross-talk and signaling leading to the modulation of a number of different biological activities including development, cell proliferation, and inflammation. This structural diversity is biosynthetically imprinted in a nontemplate-driven manner and may also be dynamically remodeled as cellular function changes. Understanding the structural information encoded in these molecules forms the basis for attempting to understand the complex biology they mediate. This chapter provides an overview of the origin of the structural microheterogeneity observed in heparin and heparan sulfate, and the orthogonal analytical methodologies that are required to help decipher this information.en_US
dc.language.isoen_US
dc.publisherSpringer-Verlag Berlin Heidelbergen_US
dc.relation.isversionofhttp://dx.doi.org/10.1007/978-3-642-23056-1_8en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourcePMCen_US
dc.titleHeparin and Heparan Sulfate: Analyzing Structure and Microheterogeneity [chapter]en_US
dc.typeArticleen_US
dc.identifier.citationShriver, Zachary, Ishan Capila, Ganesh Venkataraman, and Ram Sasisekharan. “Heparin and Heparan Sulfate: Analyzing Structure and Microheterogeneity.” Chapter in Heparin: a Century of Progress. Rebecca Lever, Barbara Mulloy, and Clive P. Page (Eds). Springer-Verlag Berlin Heidelberg (December 2, 2011): 159–176. (Handbook of Experimental Pharmacology; volume 207)en_US
dc.contributor.departmentHarvard University--MIT Division of Health Sciences and Technologyen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.mitauthorShriver, Zachary H.en_US
dc.contributor.mitauthorSasisekharan, Ramen_US
dc.relation.journalHeparin - A Century of Progressen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsShriver, Zachary; Capila, Ishan; Venkataraman, Ganesh; Sasisekharan, Ramen_US
dc.identifier.orcidhttps://orcid.org/0000-0001-9344-0205
dc.identifier.orcidhttps://orcid.org/0000-0002-2085-7840
mit.licenseOPEN_ACCESS_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record